Phosphoinositides Contribute to Organelle Identity and Function {#S1}
===============================================================

Unique enrichment of phosphoinositide phosphate (PIP) lipids across sub-cellular organelles helps to define their identity ([@B144]; [@B64]). A general theme in the field of organelle biology is that the Golgi network is defined by the presence of PI(4)P, endosomes by PI(3)P, plasma membrane by PI(4,5)P~2~ and late endosome/lysosome by PI(3,5)P~2~ ([@B144]). There are exceptions to this generalization: the plasma membrane has a substantial amount of PI(4)P and late-endosome/lysosome also bears PI(3)P ([@B159]). In addition, PI(4)P has been detected in endosomes and lysosomes ([@B65]). The organelle network is more complicated in mammals, but maintains the same basic features ([@B72]). This review focuses primarily on PI(4)P, PI(3)P, and PI(3,5)P2 because of their role in V-ATPase function.

Phosphatidylinositol 4-Phosphate, PI(4)P {#S1.SS1}
----------------------------------------

Phosphorylation of phosphatidylinositol (PI) and interconversions of PIP lipids are driven by kinases, phosphatases, and lipid transfer proteins. PI(4)P is synthesized by site-specific kinases at the Golgi and plasma membrane ([@B8], [@B9]). In yeast, Stt4 and Pik1 synthesizePI(4)P at the plasma membrane and the Golgi network respectively, the two PI(4)P-enriched locations in cells ([@B3]); the mammalian orthologs PI4KIIIα and PI4KIIIβ play similar roles ([@B48]). The lipid phosphatase Sac1 regulates pools of PI(4)P at the Golgi ([@B53]; [@B41]). Vps74/GOLPH3 interactions with Sac1 help to determine the gradient of PI(4)P in the Golgi, with highest levels in the trans Golgi ([@B164]). ER-localized Sac1 at ER-plasma membrane contact sites acts in trans to regulate plasma membrane PI(4)P, via the activity of members of lipid transfer proteins in the oxysterol binding protein family, Osh and ORP proteins ([@B143]; [@B46]). PI(4)P plays multiple critical roles in the cell, regulating trafficking, driving distribution of other lipids, and acting as a precursor for the important signaling lipids PI(4,5)P~2~ and PI(3,4,5)P~2~ ([@B152]). In yeast, PI(4)P-deficient *pik1* mutants exhibit dysregulated trafficking from the trans-Golgi network, disorganization of actin, and impairment of the secretory pathway ([@B62]; [@B157]). In addition, *pik1* mutants manifest a kinetic delay in maturation of pro-peptides destined to the vacuole from the Golgi ([@B3]). In general, defects in sorting as a result of lower PI(4)P can be attributed to failure to recruit critical trafficking effectors to the membrane, such as AP-1and GGA proteins ([@B161], [@B160]). The precise level of PI(4)P is also important, as elevation of PI(4)P in the Golgi of mammalian cells, as a result of RNAi of *SAC1*, causes mislocalization of Golgi glycosylation enzymes mannosidase-II and N-acetylglucosamine transferase-I ([@B30]). Mutations causing elevation of Golgi PI(4)P also cause mislocalization of a Golgi membrane protein in yeast ([@B164]). PI(4)P has also emerged as an important determinant of distribution of other lipids and overall membrane structure, as OSBP family members use PI(4)P to power exchange for phosphatidylserine, cholesterol, and other lipids at membrane contact sites ([@B34]; [@B110]; [@B1]; [@B120]). Some of the many defects arising from PI(4)P deficiency may arise from altered distribution of other lipids. Finally, plasma membrane PI(4)P acts as a precursor for PI(4,5)P~2~, a major organizer of plasma membranes, as well as the downstream signaling lipid PI(3,4,5)PP~3~ ([@B10]).

Phosphatidylinositol 3-Phosphate, PI(3)P and Phosphatidylinositol 3,5-Bisphosphate, PI(3,5)P~2~ {#S1.SS2}
-----------------------------------------------------------------------------------------------

Phosphatidylinositol 3-Phosphate has a critical role in vesicular trafficking and protein sorting ([@B144]). PI(3)P synthesis at the endosome relies on the PI 3-kinase Vps34. PI(3)P synthesis is critical to sorting of vacuolar proteins ([@B134]; [@B140]), and also important for endosomal maturation and subsequent synthesis of PI(3,5)P~2~ in the late endosome and lysosome ([@B24]; [@B57]). PI(3)P is essential for autophagosome formation and maturation, and therefore regulates autophagy ([@B156]; [@B105]). Vps34 participates in two different complexes that target these distinct cellular functions ([@B83]). Protein sorting and membrane trafficking are mediated by an endosomal Vps34 complex that also contains Vps15, Vps30/Beclin and Vps38/UVRAG ([@B131]). Starvation induced autophagy ([@B78]) and cytosol to vacuole transport ([@B85]) require a complex of Vps34, Vps15, Vps30/Beclin, Vps38, Atg14, and Atg38/NRBF2 ([@B2]). PI(3,5)P~2~ is generated from PI(3)P and required for endo/lysosomal maturation, luminal acidification, and merging with multi-vesicular bodies (MVB) ([@B49]; [@B118]; [@B159]). PI(3,5)P~2~ controls organelle fusion and fission by regulating the Ca^2+^ concentration of organelle lumen ([@B47]). PI(3,5)P~2~ at the endo/lyososome is dynamically regulated by hyperosmotic stress, which offers protection from osmotic stress ([@B19]; [@B76]). An intricate regulation of PI(3)P and PI(3,5)P~2~ might be responsible for endo/lysosomal positioning, trafficking and signaling ([@B159]). PI(3,5)P~2~ appears to be regulated at the endo/lysosome in response to availability of glucose ([@B168]). This is accomplished by the nutrient-sensing kinase, AMPK, in collaboration with the BORC1 complex, a regulator of lysosome trafficking ([@B168]).

Endosomal sorting has recently been implicated in multiple diseases, illuminating the crucial role of the endosome as a sorting hub in humans ([@B82]). In mammalian cells, PI(4,5)P~2~ is required for the early endocytic step and there is a PI(4,5)P~2~ to PI(3)P conversion during formation of early endosomes ([@B173]). From the endosomes, cargos are recycled to plasma membrane through recycling endosomes which require a switch of PI(3)P to PI(4)P ([@B82]). In contrast, anterograde maturation of endosomes requires PI(3)P and eventually, PI(3,5)P~2~ in the membrane, as they become late endosomes and ultimately merge with lysosomes ([@B159]). These dynamic PIP interconversions help to balance trafficking with maintenance of organelle integrity. Experimentally, acute conversion of PIPs using chemical-genetics, optogenetics, and single vesicle studies, have greatly advanced the understanding of this field ([@B173]; [@B73]).

Interactions of PIPs With Cytosolic and Membrane Proteins {#S1.SS3}
---------------------------------------------------------

Much of the functional importance of PIPs derives from the recruitment of cytosolic proteins to specific membranes and the generation of PIP-specific conformational changes in integral membrane proteins. The majority of cytosolic or peripheral membrane proteins that bind PIPs bind through conserved PIP binding domains ([@B93]; [@B63]). The pleckstrin homology (PH) domain is a well-characterized PIP binding domain that binds to PIP isoforms selectively ([@B93]). PH domains bind PIP head groups through deep pockets lined with basic amino acids, accounting for high-affinity ([@B119]). Hydrophobic and aromatic amino acids lining the PIP binding site are thought to interact with the hydrophobic lipid bilayer ([@B93]). The FYVE domain (named after the PI(3)P binding proteins Fab1, YOTB, Vac1, and EEA1) ([@B26]; [@B93]) is another high-affinity lipid binding domain common to endosomal effectors. FYVE is a zinc finger domain bearing a binding site lined by basic amino acids that recognizes PI(3)P ([@B115]). Other canonical PIP binding domains include PX, GRAM, and F-BAR domains ([@B93]). PROPPINS are a group of proteins represented by Atg18 and Hsv2 that contain a 7-bladed β-propeller that binds to PI(3)P and PI(3,5)P~2~ ([@B14]). The PIP binding site in PROPPINS does not conform to canonical PIP binding pockets. PROPPINS bind membranes containing PI(3)P or, PI(3,5)P~2~ via basic amino acid residues forming salt bridges with the PIP headgroup and aromatic amino acids that interact with the lipid bilayer ([@B14]). A group of cytosolic proteins known as MARCKS and MRP bind PI(4,5)P~2~ via long basic amino acid-rich patches ([@B113]). These proteins bind predominantly by electrostatic interactions, and may present a less structured binding domain to the membrane.

Membrane proteins also bind PIPs, but in most cases, this binding does not involve canonical PIP-binding domains. The membrane proteins that are known to be regulated by PI(4,5)P~2~ include voltage-gated ion channels of the plasma membrane ([@B148]). These channels bind to PI(4,5)P~2~ using conserved cytosolic domains present in either their N- or C-terminal domains ([@B68]; [@B148]). Mutagenesis, structural and domain swapping studies reveal that basic and hydrophobic residues are found in the PI(4,5)P~2~-binding domains in these channels ([@B68]; [@B148]). The mammalian Ca^2+^/Na^+^ selective voltage and ligand-gated, two pore ion channels TPC1 and TPC2 are activated by PI(3,5)P~2~ ([@B16]; [@B86]; [@B136]). A cryo-EM structure of TPC1 bound PI(3,5)P~2~ reveals that basic and polar amino acid residues from cytosolic loops and helices form the PIP binding site ([@B136]). Aromatic amino acids lying proximal and planar to the lipid bilayer also affect PI(3,5)P~2~ dependent regulation ([@B136]). In contrast, PI(3,5)P~2~ binding to the N-terminal domain of TRML1 channel (homologous to yeast Yvc1) requires multiple positively charged amino acid residues ([@B47]). Interestingly, TRPML1 channels localized transiently to the plasma membrane are inactive, suggesting that activity requires localization to PI(3,5)P~2~-containing compartments ([@B169]).

Luminal pH as an Identifying Feature of Organelles {#S2}
==================================================

Organelles Have a Distinct Luminal pH {#S2.SS1}
-------------------------------------

Organelles maintain a unique and tight range of pH, which also contributes to their identity ([Figure 1](#F1){ref-type="fig"}; [@B29]). Measurement of organelle and cytosolic pH depends heavily on pH-dependent ratiometric fluorescent probes ([@B100]; [@B107]; [@B29]; [@B45]). The cytosol, nucleus and the endoplasmic reticulum (ER) maintain a near-neutral pH of approximately 7.2 ([@B61]; [@B123]; [@B29]; [@B153]). The Golgi network maintains a pH of roughly 6.7--6, gradually descending from the *cis-* to *medial*- to *trans-*Golgi compartments ([@B123]; [@B42]). Secretory granules are generally more acidic, with a pH range of 5.2--5.7 ([@B58]; [@B29]). Although organelle pH ranges are generally conserved among eukaryotes, luminal pH can vary among tissues and organisms. The endocytic pathway is composed of early, recycling, and late endosomes and lysosomes. Endosomes vary in their pH, with the pH of early and recycling endosomes in the range of 6.3--6.5 ([@B29]; [@B116]), and late endosomes with a more acidic pH of 5.5 ([@B29]; [@B153]). MVB, responsible for targeting of some lysosomal and vacuolar proteins, targeting of autophagic cargo to the late-endosome/lysosome, and secretion of exosomes, are thought to maintain an acidic pH of ∼6 ([@B35]), but the precise pH of MVB is yet to be determined. The lysosome is the most acidic organelle with a pH range of 4.7--5.5 in mammals ([@B29]; [@B153]). The pH of lysosomes can vary depending on their position with respect to the nucleus, with peripheral and central lysosomes possibly serving different functions ([@B77]; [@B127]). Yeast vacuoles have many similarities to lysosomes in higher organisms, but vacuoles maintain a higher pH range of 5.5--6.2 ([@B153]), and vacuolar pH can vary substantially in response to extra- and intra-cellular cues ([@B107]; [@B44]; [@B23]).

![Distribution of V-ATPase isoforms, PIP lipids and the pH of subcellular organelles. Subcellular localization of isoforms of the 100 kDa a-subunit of the V-ATPase, in yeast and mammals, are indicated by separately coloring the a-subunit isoforms. The key to the respective a-subunit isoforms are indicated on the right side of the figure. On the left bottom, a key to the different organelles in the figure is present. The distinct enrichment of PIP lipids on the membranes of subcellular organelles and compartments are indicated by different colors. The key to the color-coded PIP species is on the bottom right side of the figure. Enrichment of PI(4)P is indicated in the compartments of the Golgi network and the plasma membrane. In addition to PI(4)P, the plasma membrane maintains an enrichment of PI(4,5)P~2~ and PI(3,4,5)P~3~. Secretory vesicles are also indicated to be enriched in PI(4)P. The endosomal compartments, including the early-, late- and recycling-endosomes and lysosomes, are characteristically enriched in PI(3)P. The late endosomes and lysosomes, in addition, maintains the highly regulated species PI(3,5)P~2~. pH or pH-ranges of all the different organelles are indicated by numbers inside or beside the respective organelles.](fcell-08-00510-g001){#F1}

Luminal pH and Organelle Function {#S2.SS2}
---------------------------------

Luminal pH is closely tied to organelle function. The strongly acidic environment of lysosome and vacuoles is optimal for the activity of various hydrolytic enzymes such as proteases ([@B97]; [@B108]). The pH gradient across lysosomes and vacuoles is utilized to drive transport of ions and metabolites in and out of lumens of these hydrolytic and storage organelles ([@B97]; [@B27]). Chemical agents and mutations that alkalinize the Golgi lumen dysregulate protein glycosylation, impair transport, and alter Golgi morphology ([@B5]; [@B103]). Mutations in a Golgi subunit-isoform of the V-ATPase (ATP6V0A2) affect Golgi acidification and cause the rare congenital human disease cutis laxa ([@B89]; [@B52]). The exocytosis machinery, particularly regulated secretory granules, require adequate acidification to perform efficient secretion. Chromaffin granules maintain an acidic pH (pH ∼5.5), and it is proposed that luminal pH is sensed in order to discriminate vesicles loaded and ready for secretion ([@B126]). Acidification of synaptic vesicles \[with pH ranging from 6.4 to 7 ([@B52], [@B51])\] is key to neurotransmission. Loading of neurotransmitters into synaptic vesicles exploits both the pH gradient across their membrane and membrane potential established by the V-ATPase proton pump to load neurotransmitters ([@B52]). Additionally, synaptic vesicle pH appears to control neurotransmitter release, subsequent to loading ([@B66]; [@B126]; [@B17]).

Endosomes are key protein and membrane sorting compartments. Release of ligands from receptors is regulated by endosomal pH, with some receptors, such as transferrin receptor, readily recycled back to the plasma membrane, while other receptor-ligand complexes such as EGF receptor proceed to the lysosome for degradation ([@B56]; [@B4]). Some receptors transmit distinct signals from endosomes ([@B15]). Multiple viruses, including influenza and coronaviruses, exploit the acidic environment of endosomes to drive conformational changes required for infection ([@B91]; [@B38]). Phagosomes become progressively more acidic as they enter the cell, and this acidification is important to their function in innate immunity ([@B151]). pH homeostasis in the endolysosomal pathway is increasingly implicated in metabolic control, proteostasis, aging, neuro-protection, adaptive immunity and inflammation ([@B27]; [@B92]; [@B18]).

Finally, the plasma membrane plays a critical role in cellular pH homeostasis. A network of transporters, exchangers, and ATPases is dedicated to maintenance of cytosolic pH in the face of changing extracellular environment ([@B60]). Tight control of cytosolic pH is essential in mammalian cells, where cytosolic acidification is a trigger for apoptosis ([@B135]). Rapidly growing cancer cells are often highly dependent on acid-producing glycolytic metabolism and remodel the plasma membrane proteome to support H^+^ export, but at the same time establish an acidic extracellular environment optimal for metastasis ([@B145]). In contrast, in some contexts, including distal renal tubule, epididymis, inner ear and osteoclasts, proton export is essential to achieve physiological functions, such as urine acidification, spermatogenesis, hearing, and bone resorption, respectively ([@B20]; [@B22]).

V-ATPase---Evidence for Direct Interaction With PIP Lipids {#S3}
==========================================================

V-ATPase Structure and Function {#S3.SS1}
-------------------------------

V-ATPases are central players in organelle acidification and cellular pH control. V-ATPases are highly conserved, multisubunit proton pumps comprised of a peripheral membrane subcomplex called the V~1~ sector, and an integral membrane subcomplex called the V~o~ sector. The structure and subunit composition of the yeast V-ATPase is shown in [Figure 2](#F2){ref-type="fig"}. Hydrolysis of cytosolic ATP occurs alternately at three catalytic sites in the V~1~A subunits, driving rotation of the central DF rotor stalk. The DF rotor stalk is attached to V~o~ d subunit and the ring of c-subunits in the V~o~ sector, and rotation of the c-ring relative to the integral membrane C-terminal domain of the a-subunit (aCT) promotes proton transport from the cytosol into the organelle lumen or to the cell exterior. Productive coupling of ATP hydrolysis and proton pumping relies on the AB hexamer in V~1~ and the V~o~ a-subunit remaining stationary as the central stalk rotates. Three stator stalks, each containing an EG heterodimer, connect the AB hexamer to V~o~, both through direct interactions with the N-terminal domain of the a-subunit (aNT) and via indirect interactions through the H and C subunits of V~1~.

![Structure of the yeast V-ATPase holoenzyme. **(A)** Cryo-electron micrograph structure of the assembled yeast V~1~-V~o~ complex ([@B171]). A combination of the electron density and a chain trace of the different subunits is used to demonstrate the structural features of the V-ATPase holoenzyme. The subunits and distinct domains are indicated. The three distinct EG heterodimers (green and purple) are indicated by numbers on the side of the respective heterodimers. Upper-case letters indicate the subunit of the V~1~ sector and lower-cases represent the V~o~-sector subunits. **(B)** A cartoon of the V-ATPase holoenzyme together with the functions performed by the V~1~ and the V~o~ sectors is demonstrated. Precisely, the V~1~ sector performs the ATP hydrolysis which is coupled to the proton transport function of the V~o~ sector. The direction of rotation of the rotor subunits (c8c′c″dDF) is indicated by a circular arrow on the hetero-decameric c-ring (cc′c″).](fcell-08-00510-g002){#F2}

V-ATPases are ubiquitous pumps found in multiple organelles of virtually all eukaryotic cells, but their activities in different locations are regulated at multiple levels. First, several subunits can be expressed as different isoforms that show tissue- and/or organelle-specific distribution ([@B106]). These isoforms can affect catalytic properties of the pumps they contain, determine their cellular localization, and support different regulatory mechanisms. Second, V-ATPases of multiple organisms have the capacity for reversible disassembly in response to diverse signals ([@B124]; [@B146]; [@B99]; [@B112]). In response to signals for disassembly of the V-ATPase, the V~1~ sector is detached from the V~o~ sector, accompanied by downregulation of both ATP hydrolysis and proton transport. Disassembly was first observed in yeast and in the tobacco hornworm Manduca sexta, and in both settings, occurred under conditions of glucose deprivation ([@B79]; [@B149]). In V~1~ subcomplexes detached from V~o~, ATPase activity is inhibited ([@B125]) and V~o~ subcomplexes are closed to protons ([@B40]). Upon restoration of nutrients, V-ATPases were reassembled and activated. Since that time, it has become clear that reversible disassembly can occur in response to multiple signals, suggesting that the ability to reversibly disassemble is a general feature of eukaryotic V-ATPase structure ([@B154]; [@B96]; [@B17]; [@B99]; [@B121]; [@B112]). Isoform content can affect the ability of V-ATPases to disassemble ([@B81]). Third, V-ATPases can be regulated by interactions with many regulatory proteins. These include glycolytic enzymes such as phosphofructokinase and aldolase ([@B101]; [@B147]), which may couple V-ATPase activity to metabolic rate, regulators encoded by pathogens (SidK) ([@B172]), and ARNO and Arf6, which help couple trafficking to endosomal pH sensing via the V-ATPase ([@B71]). Finally, as electrogenic proton pumps, V-ATPases are highly sensitive to the activity of other transporters and their overall membrane environment. In many cellular contexts, V-ATPase activity can be limited by other electrogenic transporters creating an inside positive potential across organelle membranes, or can require transport of Cl^--^ or other anions to help balance the membrane potential. In addition, other transporters exploit the proton gradient created by V-ATPases to drive transport of other molecules ([Figure 3](#F3){ref-type="fig"}). Collectively, the net proton export activity of these transporters is referred to as the "proton leak," since it opposes the activity of the V-ATPase and results in a higher luminal pH than would be expected from the activity of the V-ATPase alone. Thus, both the activity of the V-ATPase itself and the final luminal pH are very sensitive to membrane environment.

![A unified model of proton pumps, transporters, and H^+^/ion exchangers that dynamically regulate the pH of subcellular compartments in yeast. A holistic regulation of pH of the cytosol, the vacuole, and the Golgi network is maintained by the coordinated transport of several ions. The plasma membrane Pma1 (green), vacuolar V-ATPase complex (chrome and black), and the Golgi V-ATPase complex (chrome and black) pump H^+^ out of the cytosol into the extracellular milieu, the vacuole, and the Golgi, respectively. Simultaneously, different ion transporters and H^+^/ion exchangers dynamically regulate the pH of the organelles and the cytosol ([@B97]; [@B167]). A key identifying the H^+^ pumps, ion channels, and H^+^/ion exchangers is provided at the bottom of the figure. BAA refers to basic amino acids. The arrowheads indicate the direction of ion transport.](fcell-08-00510-g003){#F3}

The V~o~ a-subunit is central to V-ATPase regulation. V~o~ a-subunits show the highest level of isoform diversity in many organisms. For example, the V~o~ a-subunit is the only subunit present as isoforms in the yeast *Saccharomyces cerevisiae*, where the Stv1 a-subunit isoform resides predominantly at the Golgi apparatus and the Vph1 isoform is predominantly at the vacuole ([@B104]). In humans, there are four a-subunit isoforms; one (a4) shows strict tissue specificity, while the others (a1, a2, and a3) are ubiquitously expressed but enriched in certain cell types. Organelle-specific enrichment is shown in [Figure 1](#F1){ref-type="fig"}. The a-subunits are comprised of an N-terminal domain (aNT) exposed to the cytosol, and a C-terminal domain (aCT) that participates directly in proton transport ([@B109]; [@B130]). Because yeast cells contain a single pair of isoforms, structural and functional differences of the two yeast a-subunit isoforms have been studied extensively. Chimeras of the aNT and aCT domains of the two yeast a-subunit isoforms revealed that information for targeting and reversible disassembly of V-ATPases appears to reside in the aNT domains, while the aCT domain dictates efficiency of coupling of ATP hydrolysis and proton transport ([@B80]). More recently, structural studies of yeast V-ATPases containing either Vph1 or Stv1 revealed very little structural difference in overall backbone structures between the complexes at 6.6--6.7 A resolution ([@B155]). Structures of the Vph1- and Stv1-containing V~o~ domains at higher resolution (3.1--3.2 A) have been obtained by cryo-EM ([@B130]; [@B155]). Again, the backbone structures proved to be very similar, even though distinct catalytic properties are observed between purified V-ATPases containing the two isoforms. Despite the fact that Vph1 and Stv1 are only 49.4% identical in protein sequence, these data indicate that the a-subunit isoforms occupy very similar positions in the V-ATPase, and more subtle, side-chain differences may account for the differences they impart to their V-ATPase complexes.

The aNT Domain as a Regulatory Hub {#S3.SS2}
----------------------------------

Substantial evidence indicates that the aNT domain of a-subunit isoforms is a regulatory hub within the pump. A number of regulatory interactions with other proteins, such as the glycolytic enzyme aldolase, are proposed to involve this domain ([@B102]). In addition, as shown in [Figure 2](#F2){ref-type="fig"}, the aNT domain falls at the interface of the V~1~ and V~o~ subcomplexes, and interacts with V~1~ subunits at two distinct stator stalks. The aNT domain itself is an extended structure, with two globular domains joined by a coiled-coil ([Figure 4](#F4){ref-type="fig"}). The globular domains have been designated the "proximal domain," which contains the N-terminus and the region adjacent to the first transmembrane domain, and the "distal domain" which is at the opposite end of the coiled coil ([@B121]). The available structures indicate significant differences in the position of the aNT domain in intact V-ATPase complexes vs. isolated V~o~ structures, and these differences impact both the proximal and distal domains ([Figure 4](#F4){ref-type="fig"}). Specifically, the aNT collapses toward the V~o~ d-subunit of the central stalk in V~o~ structures and is pulled away from this stalk by interactions with the stator stalks in intact V-ATPase structures ([@B141], [@B142]; [@B155]). These structures suggest that adjusting the position of the aNT domain may be a critical step in reassembly of the V-ATPase after glucose deprivation or other triggers inducing reversible disassembly ([@B121]). It is also possible that the aNT assumes intermediate conformations that could result in partial destabilization of the V-ATPase ([@B96]). Both the proximal and distal domains contain membrane-adjacent loops that are poorly conserved and often poorly resolved in the cryo-EM structures. The position of these loops suggest that they could be candidates for interaction with the cytosolic face of the membrane, but it is notable that they contain no established lipid binding motifs.

![Structural features of the a-subunit. **(A)** A cryo-EM based model indicating the dynamic structural re-orientation of the N-terminal domain of the a-subunit in an assembled and active holoenzyme-conformation, colored in *red* ([@B171]), and a disassembled and autoinhibited conformation in the isolated V~o~ sector, colored in *green* ([@B142]). The chain traces of the c-ring comprized of c8c′c″ is colored in gray and the spherical atoms of the d-subunit is colored in blue. **(B)** A superimposition of the cryo-EM structure of the NT-domain of Vph1 in *blue* ([@B171]) and a Phyre2 based structural model of the Stv1-NT in *gray*. Stv1NT was modeled to the available low-density structure of the Stv1-V-ATPase ([@B155]). PI(4)P and PI(3,5)P~2~ molecules are indicated with phosphates drawn in pink on the respective positions of a phosphatidylinositol lipid below the proximal and distal subdomains of the aNT domain, respectively. The PI(4)P binding site in Stv1, comprized of a W^83^KY sequence in the proximal end of the Stv1NT domain is indicated using *red* ball-and-stick atomic side chains. A PI(3,5)P~2~ recognition site in Vph1, comprized of a K^231^TREYKHK sequence in the distal end of the Vph1NT domain is indicated using *green* ball-and-stick atomic side chains.](fcell-08-00510-g004){#F4}

Vacuolar V-ATPases and PI(3,5)P~2~ {#S3.SS3}
----------------------------------

As described above, the low level signaling lipid PI(3,5)P~2~ is enriched in late endosomes and lysosomes/vacuoles. Yeast mutants defective in PI(3,5)P~2~ synthesis (*fab1* and *vac14* mutants) have greatly enlarged vacuoles that are defective in uptake of the quinacrine, a fluorescent weak base, suggesting a defect in acidification ([@B57]). Ratiometric fluorescence measurements indicated a vacuolar pH of 7 in *fab1* mutants vs. a pH of 6 in wild-type cells ([@B165]). Subsequent experiments indicated that vacuolar pH could be maintained at wild-type in the absence of PI(3,5)P~2~ ([@B70]). V-ATPase activity and proton pumping were assessed in vacuolar vesicles isolated from *fab1* and *vac14* mutants ([@B96]). Both activities were approximately 50% of that in wild-type; this may well be sufficient to maintain vacuolar pH in the absence of pH challenges. The levels of Vph1 were comparable in wild-type and mutant vacuoles, suggesting that there was not a defect in trafficking of V~o~ subunits to the vacuolar membrane. V~1~ subunits were present at wild-type levels in the mutants, but at reduced levels at the vacuolar membrane, suggesting a defect in biosynthetic assembly or stability of the V-ATPase complex. Interestingly, salt stress, which transiently increases PI(3,5)P~2~ by up to 20-fold, generated an almost twofold increase in V-ATPase activity, accompanied by increased levels of V~1~ subunits, in wild-type vacuolar vesicles ([@B96]). This response was missing in vacuoles from salt-treated *vac14* mutant vacuoles. These data suggested that PI(3,5)P~2~ is not absolutely required for V-ATPase assembly or activity, but is required for full activity and for activation in response to osmotic challenge.

Preliminary evidence suggested that Vph1-containing V~o~ domains might bind to PIP lipids, so the N-terminal domain of Vph1 (Vph1NT) was visualized as a GFP fusion. The Vph1NT-GFP fusion was cytosolic in wild-type cells, but was recruited to membranes when PI(3,5)P~2~ levels were increased transiently by salt shock or constitutively in a *FAB1* mutant that maintains high levels of PI(3,5)P~2~ ([@B96]). Significantly, replacing full-length Vph1 with the Vph1NT mutant abolishes V~o~ domain assembly and the V~1~ sector does not bind to Vph1NT ([@B75]; [@B43]). Therefore, these data suggested that Vph1NT has the capacity to interact with membranes in response to PI(3,5)P~2~ levels, and could bind to the lipid directly or indirectly. PI(3,5)P~2~ activation of the V-ATPase was pursued biochemically by assessing activation of V-ATPase activity in isolated vacuolar vesicles by short chain lipids ([@B11]). Short chain PI(3,5)P~2~ activated both ATPase and proton pumping activity of wild-type vacuolar vesicles, while short chain PI(4)P and PI(3)P provided little or no activation. Mutations in loops in both the proximal and distal domains of Vph1NT were designed that disrupt basic residues predicted to point toward the outer leaflet of the membrane and were not conserved in Stv1NT ([@B11]). These mutations were introduced into full-length Vph1. Two sets of mutations, both in the distal domain of Vph1NT ([Figure 4](#F4){ref-type="fig"}), prevented activation by short chain PI(3,5)P~2~ in isolated vacuolar vesicles, while preserving wild-type basal V-ATPase activity ([@B11]). Cells containing these mutations exhibited no growth defect in the absence of stress, but had significant growth defects in a strain sensitized by deletion of the Hog1 stress-responsive transcription factor, as described below.

Golgi V-ATPases and PI(4)P {#S3.SS4}
--------------------------

As described above, the Golgi apparatus is enriched in PI(4)P, and in yeast, V-ATPases containing the Stv1 a-subunit isoform are localized to the Golgi at steady state. Remarkably, Stv1NT localizes constitutively to puncta, and this localization is lost when Golgi PI(4)P levels are reduced in a *pik1*^*ts*^ mutant, suggesting that Stv1NT binds to PI(4)P in vivo ([@B12]). *In vitro* experiments with bacterially expressed Stv1NT supported direct and specific binding to PI(4)P both on PIP blots and in liposome flotation assays. Potential PIP binding mutations were designed as described above, and a single point mutation ([Figure 4](#F4){ref-type="fig"}) in the proximal domain of Stv1NT almost completely abolished flotation of Stv1NT with PI(4)P-containing liposomes *in vitro* ([@B12]). This mutation (K83A) had been previously characterized as affecting retrieval of Stv1-containing V-ATPases from the endosome to the Golgi ([@B55]). Consistent with those data, the mutant Stv1-containing V-ATPases escaped from the Golgi to the vacuole. A similar effect was seen for Stv1-V-ATPases in a *pik1*^*ts*^ mutant, suggesting that loss of PI(4)P binding affects Golgi retention of V-ATPases ([@B12]). Stv1-containing V-ATPases were recently purified for cryo-EM studies, and addition of PI(4)P resulted in a 1.9-fold increase in ATPase activity ([@B155]). These data indicate that PI(4)P binding to Golgi V-ATPases is important for both their activity and localization in yeast.

These experiments suggest both structural correlates that can be applied to other V-ATPases and a potential range of physiological functions for PIP binding to V-ATPases. The strategy of predicting potential binding sites based on: (1) position of side chains relative to the membrane in structures or models, (2) regions of limited homology between isoforms, and (3) the presence of basic residues or clusters is consistent with PIP binding sites for other membrane proteins. The experiments with the yeast subunit isoforms suggest that PIP binding can affect activity of V-ATPases, and stabilize V~1~-V~o~ interactions ([@B96]). Interestingly, the potential binding sites identified in Vph1NT and Stv1NT are present at opposite ends of the aNT domain. The mechanistic basis of V-ATPase activation by PIP lipids is not yet clear, but structural information about aNT positioning in isolated V~o~ sectors vs. intact V-ATPases suggests some possible mechanisms. As shown in [Figure 4](#F4){ref-type="fig"}, cryo-EM structures indicate that both the proximal and distal domains of Vph1NT collapse from a more peripheral position dictated by interactions with the peripheral stator stalks in fully assembled V-ATPases toward a more central position, near the central stalk V~o~ d subunit, in isolated V~o~ subcomplexes ([Figure 4](#F4){ref-type="fig"}). Interactions with PIP lipids could potentially help stabilize aNT domains in a more peripheral position similar to that seen in the fully assembled, active enzyme.

Although it is not possible to directly identify orthologs of Vph1 and Stv1 in mammalian V-ATPases, there is good evidence that the human a2 isoform is important in Golgi function, since loss of function in this subunit leads to phenotypes associated with loss of Golgi function ([@B89]). Consistent with the results with yeast Stv1, the expressed human a2NT proved to bind specifically to PI(4)P-containing liposomes in a lipid flotation assay ([@B12]). Interestingly, a2NT does not contain the equivalent of the Stv1 K84 that was required for PI(4)P binding, suggesting that other areas of the protein support binding. However, this result suggests that a2-containing V-ATPases in the Golgi could respond to the presence of PI(4)P. As structures of higher eukaryotic V~o~ a subunit isoforms and improved models become available, it should be possible to address potential PIP binding sites and test their functional importance by methods similar to those used in yeast. These experiments are motivated by multiple connections between PIP lipids and pH regulation that may directly or indirectly involve direct interactions with the V-ATPase.

Can PIP Lipids Affect V-ATPase Function *In Vivo*? {#S4}
==================================================

The effects of mutations that compromise PIP binding to V-ATPase subunit isoforms suggest that PIP binding can affect V-ATPase function in multiple ways. PI(4)P appears to help retain Stv1-containing V-ATPases in the Golgi, but also activates these V-ATPases *in vitro*. This suggests that PI(4)P availability may both activate Stv1-containing V-ATPases when they reach the Golgi, their primary organelle of residence, and help to maintain their localization there. In this context, PI(4)P binding to the V-ATPase Golgi-specific isoform plays a fundamental role in organelle identity. Effects of PI(3,5)P~2~ on Vph1-containing V-ATPases may be more complex, perhaps reflecting the function of PI(3,5)P~2~ as a low-level signaling lipid responsive to multiple signals. Assembled V~o~ domains are present at wild-type levels in mutants lacking PI(3,5)P~2~, suggesting that neither localization nor retention of the V-ATPase requires this lipid ([@B96]). Vacuolar vesicles from mutants lacking PI(3,5)P~2~ have reduced activity and assembly, suggesting that PI(3,5)P~2~ may activate the V-ATPase by stabilizing binding of the V~1~ sector to V~o~ ([@B96]). Furthermore, mutations in Vph1 that abolish activation by PI(3,5)P~2~ do not affect basal V-ATPase activity ([@B11]). These data suggest that PI(3,5)P~2~ interactions with Vph1 may be most important under conditions of stress. Under conditions of osmotic or salt stress, the vacuole serves as a first line of defense, protecting the cytosol from high levels of ions such as Na^+^ through the action of Na^+^/H^+^ antiporters before protective transcriptional responses, from pathways such as the Hog MAP kinase pathway, can be activated ([@B95]). These antiporters operate at the expense of the vacuolar pH gradient ([@B95]), creating a need for V-ATPase activation that may be fulfilled by PI(3,5)P~2~ synthesis and V-ATPase activation. Both PI(3,5)P~2~ synthesis and V-ATPase activity are activated by salt, and this response is entirely missing in *fab1Δ* and *vac14Δ* mutants ([@B19]; [@B96]). *vph1* mutants defective in PI(3,5)P~2~ activation have no obvious growth defects, but show synthetic phenotypes in combination with *hog1Δ* mutants ([@B11]). This suggests an important stress-dependent role for PI(3,5)P~2~ activation of V-ATPases that may operate in other contexts as well. It should be noted, however that although PI(3,5)P~2~ also promotes vacuolar acidification in plants, it does not act by increasing V-ATPase activity. Instead patch clamp experiments on isolated vacuoles indicate that PI(3,5)P~2~ acts as a negative regulator of the anion/H^+^ exchanger CLC-a ([@B28]) thus limiting H^+^ export from the vacuole.

One of the prominent effects of loss of PI(3,5)P~2~ synthesis is formation of a greatly enlarged vacuole in yeast and cytosolic vacuolation in mammalian cells ([@B57]; [@B32]; [@B170]). This phenotype may have a relationship to altered V-ATPase activity, but the exact mechanism remains unclear. Yeast mutants lacking all V-ATPase activity do not have greatly enlarged vacuoles, although there are defects in vacuolar morphology ([@B6]). The *vph1* mutations that prevented PI(3,5)P~2~ activation had significantly enlarged vacuoles relative to wild-type cells in the absence of salt, and less vacuolar fragmentation upon salt stress ([@B11]), but these phenotypes were not as pronounced as in PI(3,5)P~2~-deficient mutants. A screen for mutations able to suppress the temperature sensitivity of a *fab1Δ* mutant identified mutations in *VPH1* as well as a vacuolar cation/H^+^ antiporter, Vnx1; these suppressors also reduced vacuolar size ([@B163]). The V-ATPase inhibitor bafilomycin A1 prevented vacuolar enlargement in a *fab1*^ts^ mutant upon a shift to high temperature, also suggesting that reducing V-ATPase activity reduced vacuolar swelling ([@B163]). In addition, bafilomycin A1 blocks cytosolic vacuolation arising from treatment of COS7 cells with a PIKfyve inhibitor ([@B37]). This observation suggests that the relationship between the V-ATPase and vacuolation is conserved in mammalian cells. These results are not easily reconciled with PI(3,5)P~2~ activation of the V-ATPase, but in yeast, loss of PI(3,5)P~2~ and vacuolar enlargement were accompanied by elevated cellular levels of K^+^ ions (and to a less extent Na^+^ and Ca^2+^ ions) suggesting that vacuolar enlargement is a consequence of perturbed osmotic regulation ([@B163]). In this mechanism, hyperactive uptake of ions into the vacuole, likely via H^+^-driven antiporters, drives vacuole swelling; inhibiting the V-ATPase prevents the overactive uptake by inhibiting the antiporters. There is no direct evidence that a similar mechanism explains the cytosolic vacuolation in mammalian cells lacking PI(3,5)P~2~. Notably, it has been shown that overexpression the Ca^2+^ release channel TRPML1 and its yeast homologue Yvc1 can suppress vacuolation in PI(3,5)P~2~-deficient mouse fibroblasts and yeast, possibly by altering fission and fusion events ([@B47]). Lysosomal enlargement with acute PIKfyve inhibition appears to occur via lysosomal fusion ([@B33]). Both PI(3,5)P~2~ and the V-ATPase are implicated in yeast vacuolar fission and fusion ([@B6]; [@B114]), but it is not yet clear whether they act together or in parallel.

V-ATPase activity is compromised in mutants lacking Vps34, the kinase responsible for generating PI(3)P, as well as its partner regulatory subunit Vps15 ([@B132]). *vps34Δ* and *vps15Δ* mutants were identified as exhibiting Vma^--^ growth phenotypes in a genomic screen, and these mutants showed little uptake of quinacrine into the vacuole. Because PI(3)P is the substrate of Fab1/PIKfyve, PI(3,5)P~2~ synthesis is also lost in mutants unable to synthesize PI(3)P, but the V-ATPase defects exceeded those of the *fab1Δ* mutant in yeast. Vacuolar vesicles isolated from *vps34Δ* and *vps15Δ* mutants had only 15--17% of wild-type activity, and had reduced levels of both V~1~ and V~o~ subunits, despite the presence of normal subunit levels in whole cell lysates ([@B132]). These data indicate an additional defect in trafficking of Vph1-containing V-ATPases in mutants lacking PI(3)P that could be explained by transport of the V-ATPase to the yeast vacuole through the prevacuolar compartment, a Vps34-dependent pathway ([@B21]). Although mammalian cells have three PI 3-kinases, the Vps34 homologue (also known as PIK3C3) plays a critical role in endosomal trafficking and autophagy and forms the predominant pool of PI(3)P that is the precursor of PI(3,5)P~2~ ([@B74]). Recently, inhibition of cytosolic vacuolation in response to PIKfyve inhibition by bafilomycin was shown to involve attenuation of the elevated PI(3)P levels that generally accompany inhibition of PI(3,5)P~2~ production ([@B133]). These results highlight the importance of the V-ATPase in maintaining PI(3)P levels when PIKfyve is inhibited and suggest a potential role for PI(3)P in cytosolic vacuolation beyond acting as a PI(3,5)P~2~ precursor. The direct effects of Vps34-generated PI(3)P on V-ATPase activity in mammals has yet to be examined, but there are multiple connections between PI(3)P and compartment acidification that may relate to V-ATPase function, as described below.

Intersections of PIPs and Organelle pH in Health and Disease {#S5}
============================================================

Beyond direct connections to the V-ATPase, the interplay between PIP lipids and pH homeostasis occur at a very basic level. Many of the PIP lipid headgroups, including PI(3,5)P~2~ and PI(4)P have near-neutral pKa values when evaluated in a mixed lipid membrane environment ([@B88]). This pH sensitivity is physiologically relevant, since it was recently shown that PI(4)P exhibits cytosolic pH-sensitive interactions with protein effectors containing PH domains, including the lipid exchange protein Osh1. This pH sensitivity renders the interaction glucose-sensitive and leads to altered trafficking of proteins to the membrane in glucose-deprived cells ([@B137]). In contrast, levels of PI(3)P are sensitive to luminal pH. As the internal pH of endosomes and phagosomes decrease, Vps34 gradually dissociates from the cytosolic face of the membrane, halting PI(3)P production and rendering the lipid susceptible to phosphatases ([@B117]). Taken together, these data highlight the intimate connection between PIP content and pH homeostasis. These connections play out in multiple settings.

Neurodegeneration {#S5.SS1}
-----------------

Both PI(3,5)P~2~ and V-ATPase activity have strong associations with neurodegenerative disease. Mice with impaired PI(3,5)P~2~ synthesis exhibit severe neurodegeneration ([@B32]; [@B170]), and mutations that reduce PI(3,5)P~2~ levels in humans are associated with Charcot-Marie-Tooth disorder 4J and amyotrophic lateral sclerosis ([@B32]; [@B31]). Fig4- and Vac14-deficient mice show early neurodegeneration that has been attributed to defects in autophagy as well as the defective trafficking leading to vacuolation ([@B54]). Although complete loss of V-ATPase activity is lethal in mammals ([@B150]), compromised lysosomal acidification is associated with multiple neurodegenerative diseases and aging ([@B36]; [@B139]). One form of Batten's disease arises from mutations in the CLN1 gene which compromise trafficking of the a1 subunit isoform and results in elevated lysosomal pH and severe neurodegeneration ([@B7]). Mutations in LRRK2 (leucine-rich repeat kinase 2) are strongly associated with Parkinson's disease, and LRRK2 was recently shown to interact with the a1 subunit isoform. Significantly, the pathogenic LRRK2 R1441C mutation alters interaction with a1 and increases lysosomal pH ([@B158]). Loss of the a1 subunit has also been associated with Alzheimer's disease ([@B162]). Mutations associated with altered splicing of human V-ATPase subunit gene ATP6AP2 are associated with both a specific form of Parkinson's disease, X-linked parkinsonism with spasticity ([@B90]) and X-linked mental retardation with epilepsy, Hedera type ([@B129]; [@B69]). Conditional deletion of ATP6AP2 in mouse brain results in severe developmental defects and widespread neurodegeneration ([@B69]), and similar defects were seen in Drosophila ([@B50]). Autophagic flux requires V-ATPase activity both for autophagosome-lysosome fusion and autolysosome acidification/cargo degradation ([@B108]). Long-lived cells like neurons are particularly sensitive to reduced lysosomal proteolysis. Oocytes are also generally long-lived cells, and interestingly, stimulation of V-ATPase activity proved to be critical for restoring oocyte proteostasis prior to fertilization in *Caenorhabditis elegans*, thus insuring a "reset" that clears any accumulated aggregates ([@B18]). If PI(3,5)P~2~ proves to activate V-ATPase activity in response to stress in mammalian cells as it does in yeast, this activation could be a pathway for neuroprotection.

Phagocytosis and Immunity {#S5.SS2}
-------------------------

As described above, proteins entering the cell via endocytosis encounter a progression of compartments with distinct luminal pH and phosphoinositide content. This progression is even more elaborate in phagocytic cells, which display both a succession of transitions in PIP lipid content and a progressively lower pH with time. [@B151] found that V-ATPases containing the a3 subunit isoform were responsible for phagosome acidification, and were recruited to phagosomes by phagosome-lysosome fusion. The a3 isoform appeared at the phagosomal membrane by 10 min. after phagocytosis of latex beads, and remained on the membrane through later stages of phagocytosis. During these stages, the phagosomal pH decreased from 7.5 to 5.9. Both phagosome acidification and bacterial killing were lost in macrophages from a mutant mouse lacking the a3 subunit ([@B151]). Interestingly, it was recently shown that if reacquisition of PI(4)P in late phagosomes is blocked, acidification of the phagosome is compromised ([@B94]). As in a number of cases, it is not yet clear whether PI(4)P facilitates fusion with acidic lysosomes with the phagosomes at this later stage, directly affects acidification, or both. Reduced PI(3,5)P~2~ was shown to compromise phagosome-lysosome fusion and degradative capacity in RAW macrophages, but acidification of both phagosomes and lysosomes was preserved, suggesting that acidification is not dependent on this lipid ([@B84]). Dendritic cells process endocytosed proteins for antigen presentation, and increased assembly of the V-ATPase in lysosomes accompanies dendritic cell maturation and results in a lower lysosomal pH ([@B154]; [@B98]). More recently, PIKfyve was shown to be critical for maturation of phagocytic compartments in dendritic cells and generation of an "MHC Class II compartment" where protein fragments are combined with MHC Class II molecules for antigen presentation. Inhibition of PIKfyve in dendritic cells impaired lysosomal acidification and antigen presentation, slowing maturation of the phagocytic compartment and reducing the activity of proteases with an acidic pH optimum ([@B13]). In a *Dictyostelium* model of phagocytosis, loss of PI(3,5)P~2~ decreased acidification and increased survival time of *Legionella* bacteria ([@B25]). Many pathogens, including *Legionella* and *Mycobacterium tuberculosis*, manipulate both PIP levels and organelle acidification to modify the phagocytic pathway and enhance their survival ([@B67]; [@B87]). The cellular entry and intracellular life-cycle of SARS-Cov-2 virus was blocked both by V-ATPase and PIKfyve inhibitors in a human pseudovirus infection model, indicating an important role of ion homeostasis at the endo-lysosome in coronaviral propagation ([@B122]). Taken together, these data emphasize the importance of both PIP lipids and the V-ATPase in immunity. They indicate multiple intersections between PI(3,5)P~2~ production and the acidification of compartments required for antigen presentation and pathogen killing. Future experiments are needed to determine whether it is possible that PI(3,5)P~2~ is essential for fusion of lysosomes with the maturing phagosome in certain settings and/or directly activating the V-ATPase in others.

Cancer {#S5.SS3}
------

Both V-ATPases and PIPs play important signaling roles in cancer ([@B145]; [@B59]), but they also exhibit critical interactions in the endomembrane system that may not be directly related to signaling. Certain cancers are addicted to autophagy, and treatment with the weak base chloroquine inhibited growth of pancreatic tumors in mice ([@B166]). The importance of V-ATPase function and Vps34-containing complexes in autophagy are described above. V-ATPase activity is upregulated in cancer, and this upregulation is associated with both drug resistance and metastasis in a number of cancers ([@B145]). Upregulation of lysosomal V-ATPases enhances drug resistance by promoting sequestration of chemotherapeutics. In addition, three of the four mammalian a-subunit isoforms have been implicated in recruitment of their V-ATPase subpopulations to the plasma membrane. In cancer cells with oncogenic RAS activation mutations, which require metabolic adaptations, recruitment of V-ATPases containing the a3 isoform to the plasma membrane was essential for inducing nutrient uptake by macropinocytosis ([@B128]). In human breast cancer, upregulation of the a3 isoform is associated with increased invasion and metastasis, and V-ATPases containing a3 are recruited to the plasma membrane in cancer cells but not in normal breast epithelial cells ([@B39]). In a mouse breast cancer model, V-ATPases containing the a4 subunit isoforms were recruited to the plasma membrane ([@B111]). In a prostate cancer cell line, both the a1 and the a3 subunit isoforms were shown to recruit from different compartments to the plasma membrane ([@B138]). In each of these cell types, V-ATPases containing the a-subunit isoforms occupied internal compartments, where they may have contributed to cell proliferation, but were also recruited to the plasma membrane, potentially to assist with pH homeostasis and reduce extracellular pH. Interestingly, recruitment to the plasma membrane would require them to function in a very different lipid environment. Specifically, V-ATPases containing the a1 and a3 generally occupy late endosomes and lysosomes enriched in PI(3)P and PI(3,5)P~2~, and movement to the plasma membrane requires them to function in the absence of these lipids ([@B138]). It will be intriguing to see if the altered lipid environment could make these V-ATPases less responsive to certain stresses than they would be in their normal organelle environment.

Future Directions {#S5.SS4}
-----------------

Recent evidence indicates that PIPs and V-ATPase both serve as critical components of organelle identity, and play central roles in pH and endomembrane homeostasis. Dissecting direct and indirect roles of PIPs in V-ATPase regulation requires both an assessment of which populations of mammalian V-ATPases show PIP-dependent localization, activity, or regulation, and generation of tools such as mutants defective in specific PIP interactions to test the importance of those functions in various cell types. Although V-ATPases are attractive therapeutic targets in diseases ranging from cancer to osteoporosis, pursuing their potential as targets has been difficult because of toxicity associated with total loss of V-ATPase activity in mammals. PIP interactions characteristic of V-ATPase subpopulations could provide a novel mechanism for inhibiting specific V-ATPase subpopulations.
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